Skip to main content

European Epilepsy Congress (EEC), 2024

Filter
Close
Content type:
Analysis of Safety, Tolerability and Clinical Global Impression-Improvement Scale Ratings in Patients With Dravet Syndrome Enrolled as Adults in a Fenfluramine Open-Label Extension Study
Ingrid E Scheffer, Orrin Devinsky, Milka Pringsheim, et al.
Insights into Lennox-Gastaut Syndrome: A European Real-World Study on Patient Profiles and Unmet Needs
Adam Strzelczyk, Antonio Gil-Nagel, Pasquale Striano, et al.
Development of an Electronic Decision-Assisting Tool for the Evaluation of the Likelihood of Lennox-Gastaut Syndrome (LGS) Diagnosis
Nicola Specchio, Alexis Arzimanoglou, Stéphane Auvin, et al.
Comparative Effectiveness of Fenfluramine Versus Cannabidiol in Dravet Syndrome: A Numbers Needed to Treat Indirect Comparison Analysis
Carlos H. Arteaga Duarte, Sandeep Kiri, Vanessa Taieb
Pulmonary safety of Staccato®alprazolam in healthy participants and participants with mild asthma: phase 1, randomised, double-blind, placebo-controlled trial
S David Miller, Craig F LaForce, Laura Barlow, et al.
Expert Consensus Recommendations on Seizure Emergencies Suitable for Rapid and Early Seizure Termination (REST) and Timing of Intervention
Jesus Eric Pina-Garza, Michael Chez, James Cloyd, et al.
Evaluating mental health in caregivers of patients with Dravet syndrome: a systematic review
Bobby Jacob, Michael Scott Perry, Christoph Helmstaedter, et al.
Brivaracetam adjunctive therapy in earlier treatment lines in adults with focal-onset seizures in Europe and Canada: second interim results of 12-month real-world data from BRITOBA
Susanne Knake, Marco de Curtis, Eliane Kobayashi, et al.
Treatment satisfaction, work productivity, and quality of life under adjunctive brivaracetam in earlier treatment lines in adults with focal-onset seizures: 12-month real-world data from BRITOBA
Yaroslav Winter, Giovanni Boero, Giuseppe Didato, et al.
Long-Term Efficacy and Tolerability of Brivaracetam in Pediatric Patients With Focal-Onset Seizures and Cognitive or Learning Comorbidities: Post Hoc Analysis of an Open-Label Trial
Lieven Lagae, Dimitrios Bourikas, Najla Dickson, et al.
Effectiveness and Tolerability of Brivaracetam in Adults With Epilepsy Etiology of Cerebral Neoplasm, Cerebrovascular Accident, or Cranial Trauma: Pooled Data Analyses From Two Real-World Studies
Hina Dave, Michael R Sperling, Brian Moseley, et al.
Healthcare Utilization and Persistence in Patients With Dravet Syndrome: A Retrospective Analysis Using US Claims Data
Derek Ems, MPH, Srihari Jaganathan, et al.
Pharmacokinetics of Fenfluramine and its Active Metabolite Norfenfluramine in Patients with Lennox-Gastaut Syndrome
Aravind Mittur, Christopher Rubino, James Wheless, et al.
Modeling Systemic Exposure to Fenfluramine and its Active Metabolite, Norfenfluramine, in Patients With Dravet Syndrome
Aravind Mittur, Christopher Rubino, Stéphane Auvin, et al.
Automated assessment of sleep in healthy pediatrics from simulated behind-the-ear EEG
Benjamin Wittevrongel, Tanja Hellier, Julie Nys, et al.
Fenfluramine Increases Seizure-Free Days in Patients With Lennox-Gastaut Syndrome
Stéphane Auvin, Ingrid E. Scheffer, Antonio Gil-Nagel, et al.